Find high-quality animal and human-origin-free recombinant human albumins in the Recombumin ® product portfolio. Established in the UK in 1984, Albumedix, now a part of Sartorius, has supported its life science partners to deliver hundreds of millions of doses of clinical and marketed therapeutics, globally.

2022年8月8日 · The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions.

Sartorius Albumedix recombinant albumins provide high purity and consistency, offering a multifunctional ancillary, excipient and raw material that delivers dependable performance. View Products Request Your Sample. Learn how high-quality raw materials simplify the journey of cardiomyocyte therapies from lab to clinical trials.

2022年8月8日 · Albumedix将并入赛多利斯生物工艺解决方案板块，其诺丁汉现有的72,000平方英尺的场地将建成为创新中心以及符合GMP要求的关键原材料生产的卓越中心。 Milbank LLP在本次交易中为赛多利斯提供法律咨询服务。

2022年8月9日 · Life science group Sartorius has signed a definitive agreement for the acquisition of complete outstanding shares of UK-based company Albumedix from private investors in a deal valued at nearly $501.5m (£415m).

2022年8月9日 · Albumedix' solutions include the world's only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing...

2022年9月30日 · The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of Albumedix Ltd. as of September 30, 2022. Albumedix is a leader in the field of recombinant albumin-based solutions and based in Nottingham, UK.

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. They partner with excellence to improve therapies for people with serious diseases.

GÖTTINGEN, Germany, Aug. 8, 2022 /PRNewswire/ -- The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd....

2022年8月9日 · Albumedix总部位于英国诺丁汉，被公认为重组人白蛋白产品和技术的全球领导者。 重组人白蛋白是生物制药行业各种应用所需的重要成分，例如作为细胞培养基的无动物添加剂以及用于稳定疫苗和病毒疗法。